TPRA1 and prostate carcinoma: To confirm the role of TPRA1 in OVM infection, we demonstrated that silencing TPRA1 in prostate cancer 22Rv1 cells and colon cancer SW620 cells using siRNA significantly reduced virus infection rate (Figure 1D).